Obesity Surgery Devices - Global Strategic Business Report

The global market for Obesity Surgery Devices was estimated at US$1.8 Billion in 2024 and is projected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Obesity Surgery Devices market.

Global Obesity Surgery Devices Market - Key Trends & Drivers Summarized

How Are Shifting Clinical Strategies Influencing Demand for Obesity Surgery Devices?

Obesity surgery devices are gaining importance as clinical strategies shift from conservative weight management approaches to more interventional treatments for severe obesity. Rising global prevalence of obesity-related comorbidities such as type 2 diabetes, cardiovascular disease, and sleep apnea has prompted clinicians to adopt bariatric surgery more widely as a medically necessary intervention. As a result, surgical interventions such as gastric bypass, sleeve gastrectomy, and adjustable gastric banding are being used beyond cosmetic reasons to address metabolic disorders. This shift is driving consistent demand for a broad range of devices including stapling systems, gastric bands, suturing devices, and balloon systems.

Surgeons and hospitals are increasingly integrating minimally invasive devices that reduce operation time and postoperative recovery. This is expanding the role of advanced laparoscopic instruments and robotic-assisted tools in bariatric procedures. Adjustable gastric bands and endoscopic sleeves are being used selectively in patients who may not qualify for more invasive surgeries but require clinical weight loss support. Such flexibility in device selection is contributing to higher adoption rates. Additionally, guidelines and insurance coverage are evolving in several regions, further normalizing surgical treatment for obesity and increasing the volume of device-assisted interventions in public and private healthcare settings.

What Technological Shifts Are Redefining Device Innovation in This Segment?

Obesity surgery devices are undergoing notable evolution in terms of both material design and functionality. Manufacturers are focusing on creating devices that offer higher precision, ease of deployment, and reduced complications. For example, the development of biodegradable gastric balloons and enhanced suturing systems is helping address limitations related to device removal and long-term complications. Disposable laparoscopic tools and automated stapling systems are also becoming more common, especially in high-throughput surgical centers where infection control and procedural efficiency are critical.

Robotic platforms are beginning to influence surgical workflows in obesity treatment. Devices integrated with robotic arms are being designed for enhanced dexterity and precision, especially in revisional bariatric procedures. Meanwhile, innovation in endoluminal devices is supporting the growing segment of incisionless or low-risk procedures. These devices, which work entirely within the gastrointestinal tract, are being tested and adopted for weight loss in patients who cannot undergo conventional surgery. Such advancements not only improve patient outcomes but also expand the overall addressable patient base for obesity surgery devices. This is encouraging more hospitals to invest in technologically upgraded instruments and workflows.

Where Are Hospitals and Surgeons Focusing Device Use in Real-World Settings?

Hospitals and surgical centers are aligning their device preferences with population-level needs and surgical specialization. In high-obesity regions, demand for vertical sleeve gastrectomy devices remains prominent due to the balance it offers between effectiveness and procedural safety. This has led to high-volume usage of surgical staplers and energy-based dissection tools. Adjustable gastric band systems, although witnessing reduced uptake in many Western markets, are still in use in specific populations and private practices, especially where patients opt for reversible procedures. Surgeons in Asia-Pacific and Latin America continue to perform a mix of laparoscopic and open bariatric surgeries depending on infrastructure and patient profile, driving varied demand for conventional and advanced instruments.

Endoscopic and balloon-based devices are being favored in outpatient settings and ambulatory surgical centers, especially in urban areas with growing interest in non-invasive weight loss solutions. These centers are investing in intragastric balloon systems and transoral endoscopic devices that enable same-day discharge and shorter follow-up cycles. In teaching hospitals and bariatric specialty centers, robotic tools and high-definition visualization systems are being adopted to handle more complex or repeat surgeries, often involving patients with prior failed interventions. This stratification in care delivery settings is shaping the procurement and application patterns for obesity surgery devices across global markets.

Growth in the Obesity Surgery Devices market is driven by several factors

Growth in the obesity surgery devices market is driven by several factors directly linked to procedural trends, technological innovation, and healthcare practice evolution. Increasing global adoption of sleeve gastrectomy and gastric bypass as standard treatments for obesity is expanding demand for precision stapling and cutting tools. Uptake of robotic-assisted surgery for bariatric procedures is also contributing to device sales, especially those compatible with robotic platforms. Technological improvements in intragastric balloons and endoluminal suturing devices are enabling minimally invasive procedures, making such devices attractive in both private and ambulatory care settings.

Rising use of disposable laparoscopic tools in infection-sensitive environments is influencing purchasing behavior in high-volume surgical centers. Adoption of devices with better ergonomics, material compatibility, and lower risk of leakage or migration is becoming a procurement priority in hospitals. In emerging markets, increasing investments in laparoscopic surgery infrastructure and surgeon training are supporting broader usage of both conventional and advanced obesity surgery tools. In addition, expansion of insurance coverage and inclusion of obesity surgeries under public health initiatives are creating stable demand for clinically approved and reimbursement-compatible devices.

Scope Of Study:

The report analyzes the Obesity Surgery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Device (Gastric Balloons, Gastric Bands, Stapling Devices); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Gastric Balloons segment, which is expected to reach US$1.6 Billion by 2030 with a CAGR of a 6.4%. The Gastric Bands segment is also set to grow at 3.6% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $490.7 Million in 2024, and China, forecasted to grow at an impressive 8.8% CAGR to reach $502.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Obesity Surgery Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Obesity Surgery Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Obesity Surgery Devices Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Allurion Technologies, Apollo Endosurgery, Inc., Aspire Bariatrics, Inc., B. Braun Melsungen AG, Boston Scientific Corporation and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 34 companies featured in this Obesity Surgery Devices market report include:

• Allurion Technologies
• Apollo Endosurgery, Inc.
• Aspire Bariatrics, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Conmed Corporation
• Cousin Biotech
• Ethicon (Johnson & Johnson Services Inc.)
• GI Dynamics, Inc.
• Intuitive Surgical, Inc.
• Mediflex Surgical Products
• Medtronic plc
• Olympus Corporation
• ReShape Lifesciences (ReShape Medical)
• Richard Wolf GmbH
• Spatz FGIA Inc.
• Stryker Corporation
• TransEnterix (Asensus Surgical)
• USGI Medical, Inc.
• Olympus PowerSeal

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.